Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-185P is a human pseudogene derived from the U7 small nuclear RNA gene. U7 snRNA itself is an essential component of the machinery involved in histone mRNA processing, specifically for the formation of mature histone transcripts[1][3]. Pseudogenes like RNU7-185P represent genomic sequences that resemble functional snRNA genes but have lost protein-coding or functional RNA capacity—most are not transcribed, or if they are, their transcripts are generally non-functional. However, recent genomics research shows that some pseudogenes can be transcribed into non-coding RNAs and might modulate the expression of their parental gene through RNA interference, epigenetic regulation, or acting as competing endogenous RNAs. Still, there is currently no evidence for such regulatory function or disease involvement for RNU7-185P specifically[2][4][6]. The presence and annotation of pseudogenes like RNU7-185P are chiefly important for genome annotation and interpretation, rather than direct therapeutic targeting.
Not applicable; no drugs target RNU7-185P directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 185 pseudogene (RNU7-185P).